If you are looking for a cannabis-related asset that pays dividends and doesn’t have to do much to maintain its revenues, you might want to check out Innovative Industrial Properties (IIPR).


IIPR-300x234 A Cannabis REIT That Pays Dividends


Innovative Industrial Properties is a real estate investment trust, or REIT. Their business model consists of buying greenhouses in the US used for medical cannabis growers and leasing them out to medical cannabis companies for a 15-year period.

Currently, they own seven facilities: The Pharm (AZ), Holistic Industries (MD), PharmaCann (MA), Vireo Health (MN), PharmaCann (NY), Vireo Health (NY), and Vireo Health (PA).

For their first quarter earnings, the company raked-in $42.1 million in cash on hand in addition to $48.9 million in short-term investments. They are also purportedly viewing up to $100 million worth of properties for further expansion/acquisition.

What makes their business model favorable is that cash flow is expected to remain consistent and predictable. Given the 15-year lease and a relatively low-cost model, the company’s growth prospects remain at the forefront of seeking competitive property acquisitions.

Innovative Industrial Properties also returns most of its operating income to shareholders via nearly 3% dividend. Not only might this be a plus for investors, it also works out as a tax advantage for the company as REITs generally receive favorable tax status.


The risk of loss in the trading of stocks, options, futures, foreign exchanges, foreign equities, and bonds can be substantial and is not suitable for all investors. Trading on margin or the use of leverage is not suitable for all investors and losses exceeding your initial deposit is possible. Supporting documentation is available upon request. Trading futures, options on futures, and foreign exchanges involves substantial risk of loss and is not suitable for all investors. Carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources and only risk capital should be used. Opinions, market data, and recommendations are subject to change at any time. The lower the margin used the higher the leverage and therefore increases your risk. Past performance is not necessarily indicative of future results.